VIDEO: OCS-01 eye drop shows efficacy, safety for treatment of DME

CHICAGO — In this Healio Video Perspective from the AAO meeting, Arshad M. Khanani, MD, MA, FASRS, shares promising data from an ongoing phase 2/3 study investigating OCS-01, an eye drop for the treatment of diabetic macular edema.

“In stage one, we saw efficacy signals in every single parameter we looked at, and this drop was also found to be safe,” he said. “We did see an increased rate of intraocular pressure, as expected for a dexamethasone eye drop.”

Khanani also shared an update on the enrollment of the DIAMOND 1 and DIAMOND 2 phase 3 studies investigating OCS-01 (Oculis).

Published by:

Sources/Disclosures

Collapse

Source:

Healio Interviews

Disclosures:
Khanani reports being the chair of the scientific advisory board and steering committee for Oculis as well as being a member of the board of directors for Oculis.

Read more about

This post was originally published on this site